Mohammed Alotaibi
Summary
Rare Disease Specialist and Market Access Strategist with over 3 years of experience in building partnerships with healthcare stakeholders, securing market access, and improving patient outcomes. Achievements include driving a 33% increase in Alpha-Mannosidosis diagnoses through targeted healthcare professional education and expediting reimbursement processes for innovative therapies. Expertise in orchestrating cross-functional teams and aligning commercial and medical strategies to deliver transformative therapies. Committed to leveraging extensive knowledge and a results-oriented approach to excel in a Specialist role while fostering collaboration and adaptive strategies to support organizational goals.
Overview
4
4
years of professional experience
Work History
Rare Disease specialist
Biologix
02.2024 - Current
- - Increased Alpha‑Mannosidosis diagnosis rates by 33% by educating 126 physicians, geneticists and allied health professionals on clinical presentation, diagnosis and management.
- Secured reimbursement and fast‑tracked Ministry of Health listing, unlocking 25% increase in patient access and removing administrative bottlenecks across priority centres.
- Organized and delivered disease‑awareness workshops and webinars, leading to improved referral pathways and earlier diagnosis.
- Collaborated with medical, regulatory and supply‑chain teams to ensure launch readiness and prevent out‑of‑stock issues.
- Conducted market mapping and competitive intelligence to identify diagnosis gaps and inform forecasting and strategic decisions.
- Improved customer satisfaction rates through proactive problem-solving and efficient complaint resolution.
Product Specialist - Infasurf
Hikma Pharmaceuticals Company HSP
10.2021 - 02.2024
- Achieved 150% of annual sales targets for Infasurf, contributing to double‑digit market‑share growth across Saudi Arabia.
- Managed relationships with neonatologists, pharmacists and procurement leads across all Ministry of Health hospitals to ensure product availability and on‑time delivery.
- Led launch readiness activities, aligning marketing, medical affairs and supply chain to ensure successful rollout and sustained adoption.
- Identified and corrected supply imbalances, reducing obsolete stock by 41% and improving forecasting accuracy.
- Conducted market research and competitor analysis to inform promotional strategies and provide insights for future pipeline products.
- Supported sales representatives during client meetings by providing expert knowledge on specific features or functionalities of the given product line.
Education
Bachelor of Pharmacy - Doctor of Pharmacy (Pharm.D)
king saud University
5.2021
Master of Business Administration -
Amman Arab University
2024
Skills
Stakeholder Engagement & Ecosystem Alignment: Key Account Management, KOL & HCP engagement, Ministry of Health relations, patient advocacy, community partnerships
Market Access & Reimbursement: Tendering & contracting, reimbursement submissions, health economics & reimbursement strategy, MOH listing
Strategic Insights & Digital Innovation: Market research & competitive intelligence, patient journey mapping, data analysis & forecasting, CRM systems, digital education platforms
Cross‑Functional Leadership: Product launch readiness, cross‑functional collaboration across medical, regulatory, supply chain and commercial teams
Training & Negotiation: HCP education, workshop facilitation, negotiation and influencing skills
Timeline
Rare Disease specialist
Biologix
02.2024 - Current
Product Specialist - Infasurf
Hikma Pharmaceuticals Company HSP
10.2021 - 02.2024
Master of Business Administration -
Amman Arab University
Bachelor of Pharmacy - Doctor of Pharmacy (Pharm.D)
king saud University